Clinical Trial Update: Rivastigmine in the Management of Delirium [Phase 3]

View source ↗

Summary

This document notes the completion of a Phase 3 clinical trial evaluating rivastigmine for the management of delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Delirium | Phase 3 | Status: COMPLETED